Researchers

Michael Marks

447 UCB
Boulder, CO 80309-0345
phone: 303-492-9677
fax: 303-492-8063
email:
Michael.Marks@Colorado.edu

Recent Publications

Research Interests:

Genetic influences on molecular, biochemical, physiological, and behavioral factors mediating the responses to nicotine in mice.

Selected Publications:

1. Collins AC, Salminen O, Marks MJ, Whiteaker P, Grady SR.(2009). The road to discovery of neuronal nicotinic cholinergic receptor subtypes. Handb Exp Pharmacol., 192, 85-112.
PMID: 19184647 | pubmed abstract |

2. Marks MJ, Meinerz NM, Drago J, Collins AC.(2007). Gene targeting demonstrates that alpha4 nicotinic acetylcholine receptor subunits contribute to expression of diverse [3H]epibatidine binding sites and components of biphasic 86Rb+ efflux with high and low sensitivity to stimulation by acetylcholine. Neuropharmacology., 53(3), 390-405.
PMID: 17631923 | pubmed abstract |

3. Marks MJ, Whiteaker P, Collins AC. (2006). Deletion of the alpha7, beta2, or beta4 nicotinic receptor subunit genes identifies highly expressed subtypes with relatively low affinity for [3H]epibatidine. Mol Pharmacol., 70(3), 947-59.
PMID: 16728647 | pubmed abstract |